Please Note:
This profile was automatically generated using 24 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 24 references found on the Internet. This information has not been verified. Learn more...
View all 24 references Web References
-
1. MISSION POSSIBLE WORLD HEALTH INTERNATIONAL
www.mpwhi.com/report_on_aspart - [Cached]Published on: 8/4/2006 Last Visited: 1/3/2008
Wbert, A. G. Letter to Sue Ann Anderson, R.D., Ph.D., Senior Staff Scientist, FASEB. -
2. www.dorway.com
www.dorway.com/report_children - [Cached]Last Visited: 3/4/2007
Wbert, A. G. Letter to Sue Ann Anderson, R.D., Ph.D., Senior Staff Scientist, FASEB. -
3. A Study of Suppression of Information
www.truthinlabeling.org/l-manu - [Cached]Published on: 6/16/2004 Last Visited: 5/26/2008
Ebert rebutted, leading to a request from Sue Anne Anderson, R.D., Ph.D., Senior Staff Scientist with the Life Sciences Research Office at FASEB for information about the vehicle for administration of monosodium glutamate in IGTC-sponsored double blind studies.
...
In a March 22, 1991 letter to Anderson, IGTC chairman Ebert responded that "since the completion of the work described in [1978], the sample has been modified to replace the sucrose with the low calorie sweetener Aspartame in both the placebo and sample with MSG."Still, no one at the FDA raised any question about the propriety of the research being submitted to the FDA by the IGTC as evidence that MSG is safe.
In 1993, J. Samuels came across the March 22, 1991 letter to Anderson in the files of the FDA; and brought the information to the attention of both FASEB and the FDA.
